CDH1 and esophageal cancer: To investigate the clinical importance of CDH1/E-cadherin dysregulation in esophageal cancer, we firstly analyzed TCGA datasets (publicly available at cBioportal for Cancer Genomics: www.cbioportal.org) and reviewed the literature to determine the extent of CDH1/E-cadherin aberration in esophageal EAC.